GMP Protein Contract Manufacturing Market, by Product Type, by Application, by Method, by End User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022

Description

GMP Protein (E. coli) may or may not be manufactured using animal-free processes depending on the characteristics of the protein. Recombinant Protein is a protein encoded by a gene recombinant DNA that has been cloned in a system that supports the expression of the gene and translation of messenger RNA. Modification of the gene by recombinant DNA technology can lead to the expression of a mutant protein. Proteins co-expressed in bacteria will not possess post-translational modifications, e.g. phosphorylation or glycosylation. Some of the recombinant proteins which were produced and commercialized in medications are Humulin, Hematrope, Avonex, Kogenate, Pulmozyme and others.

Market Dynamics

Increasing launches of products in the market is expected to drive the growth of the global GMP protein (E. coli) contract manufacturing market over the forecast period. For instance, in June 2022, AMSBIO, a provider of quality life science research reagents and services, announced the launch of its Stem Fit Protein range of recombinant proteins for cell therapy applications. The Stem Fit Protein range includes recombinant proteins that play key roles in differentiating Embryonic Stem (ES) and induced Pluripotent Cells (iPS) in the pancreas, heart, kidney, blood, and immune cells. Moreover, in September 2021, Aviva Systems Biology, a company providing antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new Protein on Demand semi-custom GMP grade recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins allows rapid access to small- to mid-scale production of customized proteins for research teams.

Key features of the study:

This report provides an in-depth analysis of the global GMP protein (E. coli) contract manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global GMP protein (E. coli) contract manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck & Co., Inc., Thermo Fisher Scientific Inc., Abcam plc, GenScript, Biomay AG, SOL GROUP, Proteintech Group, Inc., Nordmark Pharma GmbH, Sino Biological, Inc., Sino Biological, Inc., Abnova Corporation, Eurofins Scientific, Arcline Investment Management LP, Abgenex, Xpress Biologics, Avid Bioservices Inc, Bio-Techne, Northway Biotech, Aldevron, Institut Merieux, PerkinElmer Inc., Creative BioMart, Profacgen, ProBioGen AG, 53Biologics, Leadgene Biomedical, Inc., Ajinomoto Bio-Pharma, FUJIFILM Diosynth Biotechnologies, Avioq, Inc, Biovian Oy, KBI Biopharma, GTP Bioways, QIAGEN, Suzhou Novoprotein Technology Co., Ltd., ACROBiosystems, Kactus, F. Hoffmann-La Roche Ltd., and Enzo Life Sciences, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global GMP protein (E. coli) contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP protein (E. coli) contract manufacturing market.

Detailed Segmentation:

Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type:
- Cytokines
- Growth Factors
- Enzymes
  - DNA polymerase
  - Protease
  - Trypsin
  - Nuclease
- Benzonase
- Cas9 Nucleases
- Others
  - IVT Enzymes
  - Others
- Hormones
- Antigens
- Others
Global GMP Protein (E. coli) Contract Manufacturing Market, By Application:
- Gene Therapy
- Cell Therapy
Global GMP Protein (E. coli) Contract Manufacturing Market, By Method:
- In-Vivo
- Ex-Vivo
Global GMP Protein (E. coli) Contract Manufacturing Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organizations
- Others
Global GMP Protein (E. coli) Contract Manufacturing Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Region/Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Merck & Co., Inc.
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific Inc.
- Abcam plc
- GenScript
- Biomay AG
- SOL GROUP
- Proteintech Group, Inc.
- Nordmark Pharma GmbH
- Sino Biological, Inc.
- Abnova Corporation
- Eurofins Scientific
- Arcline Investment Management LP
- Abgenex
- Xpress Biologics
- Avid Bioservices Inc
- Bio-Techne
- Northway Biotech
- Aldevron
- Institut Merieux
- PerkinElmer Inc.
- Creative BioMart
- Profacgen
- ProBioGen AG
- 53Biologics
- Leadgene Biomedical, Inc.
- Ajinomoto Bio-Pharma
- FUJIFILM Diosynth Biotechnologies
- Avioq, Inc
- Biovian Oy
- KBI Biopharma
- GTP Bioways
- QIAGEN
- Suzhou Novoprotein Technology Co., Ltd.
- ACROBiosystems
- Kactus
- F. Hoffmann-La Roche Ltd.
- Enzo Life Sciences, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Product Code: CMI5433

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Method
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
PEST Analysis
Porter's Analysis
Key Developments
Regulatory Scenario
Acquisition and Agreement Scenario
Brand Mapping

4. Global GMP Protein (E. coli) Contract Manufacturing Market- Impact of Coronavirus (Covid-19) Pandemic

Overall Impact
Impact on Supply and Demand
COVID-19 Impact on the market

5. Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Cytokines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Growth Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Enzymes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
DNA polymerase
Protease
Trypsin
Nuclease
- Benzonase
- Cas9 Nucleases
- Others
IVT Enzymes
Others
Hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Antigens
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global GMP Protein (E. coli) Contract Manufacturing Market, By Application, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Gene Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global GMP Protein (E. coli) Contract Manufacturing Market, By Method, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
In-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Ex-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global GMP Protein (E. coli) Contract Manufacturing Market, By End User, 2017 - 2030, (US$ Million)

Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Biotechnology and Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global GMP Protein (E. coli) Contract Manufacturing Market, By Region, 2017 - 2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Thermo Fisher Scientific Inc.
Abcam plc
GenScript
Biomay AG
SOL GROUP
Proteintech Group, Inc.
Nordmark Pharma GmbH
Sino Biological, Inc.
Kaneka Eurogentec S.A.
Abnova Corporation
Eurofins Scientific
Arcline Investment Management LP.
Abgenex
Xpress Biologics
Avid Bioservices, Inc.
Bio-Techne
Northway Biotech
Aldevron
Institut Merieux
PerkinElmer Inc.
Creative BioMart
Profacgen
ProBioGen AG
53Biologics
Leadgene Biomedical, Inc.
Ajinomoto Bio-Pharma
FUJIFILM Diosynth Biotechnologies
Avioq, Inc
Biovian Oy
KBI Biopharma
GTP Bioways
QIAGEN
Suzhou Novoprotein Technology Co., Ltd
ACROBiosystems
Kactus
F. Hoffmann-La Roche Ltd.
Enzo Life Sciences, Inc.

11. Section

Research Methodology
About Us

GMP Protein Contract Manufacturing Market, by Product Type, by Application, by Method, by End User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030